WEBINAR: Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery

May 9, 2017 (1 – 2 p.m. EDT)

View WebinarExternal Web Site Policy
PowerPoint Presentation (PDF) External Web Site Policy
Webinar Q&A's (PDF) External Web Site Policy

This webinar will provide an overview of the R01 and R21 funding opportunity announcements, Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery PA-17-060External Web Site Policy (R01) and PA-17-061External Web Site Policy (R21).

Dr. Wendy Nelson and Ms. Kathleen Castro provide an overview of these funding opportunities that seek research to assess and describe the current state of oral anticancer medication utilization, delivery, and adherence; identify structural, systemic, and psychosocial barriers to adherence; and develop models and strategies to improve safe and effective delivery of these agents so that clinical outcomes are optimized.

National Cancer Institute Speakers:

Wendy Nelson, PhD, MPHExternal Web Site Policy
Program Director
Basic Biobehavioral and Psychological Sciences Branch
Behavioral Research Program

Kelly Filipski, PhD, MPHExternal Web Site Policy
Program Director
Clinical and Translational Epidemiology Branch
Epidemiology and Genomics Research Program

Kathleen Castro, RN, MS, AOCN®
Program Director
Office of the Associate Director
Healthcare Delivery Research Program

Intended Audience:
Extramural investigators at junior, mid-, and senior levels.

Email your questions in advance to ncidccpsbrpadvances@mail.nih.gov. Questions about specific aims or grant application details will not be addressed.